secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001217234-24-000081
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q2 revenue $92.3M (+31% YoY); raises FY2024 revenue guidance to $320-$328M
--------------------------------------------------------------------------------

- Total revenue $92.3M (+31% YoY); Testing Services revenue $70.9M (+33%); volume 43,700 tests (+17%).
- GAAP net loss narrowed to $1.4M from $25M; non-GAAP net income $13.6M (vs loss of $9.9M).
- Adjusted EBITDA positive $12.9M vs loss of $10.4M; cash $228.9M, no debt.
- Raised FY2024 revenue guidance to $320-$328M (from $274-$282M); adjusted EBITDA guidance to $9-$15M gain.
- Expanded coverage by 27M lives in H1 2024; published SHORE study and Nature Medicine data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000081/0001217234-24-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000081/cdna-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001217234-24-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer